Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_32_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
22 Мб
Скачать
https://t.me/medicina_free
Prenatal Diagnosis
https://t.me/medicina_free
SARAH L HECHT and VIJAYA M VEMULAKONDA
Topics covered
4
Prenatal imaging Hydronephrotic anomalies Classication Diagnoses
INTRODUCTION
Since its inception in the 1970s, prenatal screen­ing with fetal ultrasonography has become nearly ubiquitous. Abnormalities of the urogenital sys­tem are among the most commonly prenatally detected congenital anomalies because of their relatively high incidence and the fact that dilata­tion of the fetal urinary tract (hydronephrosis) is readily detected on ultrasound. e overwhelm­ing majority of prenatally detected urologic abnormalities are associated with some degree of hydronephrosis. In most cases, prenatally detected hydronephrosis is a mild and/or transient ultra­sound nding. While most infants with prenatally detected hydronephrosis have a very favorable out­come, a small but signicant minority will prove to have signicant renal disease. Depending on prevailing attitudes to termination of pregnancy a small proportion may survive to term but then die shortly aer birth. Researchers and consensus panels have invested substantial eort into trying
Initial management Non-hydronephrotic anomalies Fetal intervention Counseling
to distinguish between those ultrasound nd­ings which denote clinically signicant urologic disease and ultrasound appearances which are essentially innocent ndings of little or no clinical signicance. Many studies have been undertaken with the aim of dening reliable criteria to guide the postnatal investigation and management of infants with prenatally detected hydronephrosis. However, this remains a source of controversy.
PRENATAL IMAGING
Ultrasonography
Ultrasonography is the primary imaging modal­ity during pregnancy. First trimester ultrasound is frequently obtained to conrm a viable intra­uterine pregnancy, estimate conception date, and assess nuchal pad translucency to screen for aneu­ploidy. However, this is of limited value in screening for most congenital anomalies. e World Health
43
44 Prenatal Diagnosis
https://t.me/medicina_free
Organization recommends a single ultrasound prior to 24 weeks gestation. In the United States, the primary anatomic survey is obtained at 18–22 weeks gestational age, with additional scans being performed in high risk pregnancies or if a congeni­tal anomaly is suspected. e second trimester scan usual ly provides sucient anatomica l detail to screen for major congenital anomalies. Additional infor­mation includes the position, size and movement of the fetus, heart rate, placental position, and the vol­ume of amniotic uid. e sensitivity and specicity of prenatal ultrasonography for the detection of con­genital anomalies depends on many factors includ­ing maternal obesity, fetal position, sonographic equipment, and experience of the person perform­ing the scan. Most of the serious, potentially lethal genitourinary anomalies, such as posterior urethral valves and bilateral renal agenesis are detected in the second trimester. However more common anoma­lies such as vesicoureteral reux, ectopic ureters, and ureteroceles are not reliably detected at this stage in gestation and may not be detected prenatally unless further scans are performed later in pregnancy.
Magnetic Resonance Imaging
During the last two decades, prenatal magnetic resonance imaging (MRI) has been gaining pop­ularity as a means of providing more detailed information on fetal abnormalities detected by prenatal ultrasound. MRI has higher so tissue contrast resolution and is not limited by maternal habitus, fetal position, ossied structures or oligo­hydramnios. MRI does not use ionizing radiation and poses no known risk to the fetus. Common applications in urological diagnosis include dis­tinguishing hydronephrosis from cystic abnor­malities, delineating ureteral anatomy including duplication, ectopia, and ureteroceles, and clarify­ing the anatomy of complex anomalies such as clo­acal anomalies and exstrophy-epispadias complex.
e reported incidence of fetal hydronephrosis ranges from 0.5% to 5% but this gure varies according to the gestational age at which scans are performed. Mild prenatally detected hydro­nephrosis is usually an innocent ultrasound nd­ing which represents a transient physiologic state of no clinical signicance. e overall incidence of antenatally detected hydronephrosis associ­ated with a clinically signicant uropathy is approximately 0.2%. It is important to minimize unnecessary investigation and repeated scans so as not to exacerbate parental anxiety. ere is a broad correlation between the degree of hydro­nephrosis and the probable severity of the abnor­mality aecting the kidneys and/or urinary tract. Several classication systems have been devel­oped to grade the severity of fetal hydronephrosis and guide further investigation but there is no consensus on which is the best for this purpose.
Classication Systems
Anterior-posterior renal pelvic diameter
is system classies the severity of hydrone­phrosis based solely on the degree of dilatation of the renal pelvis. It is based on measurements of the anterior-posterior (AP) diameter of the renal pelvis in the transverse plane at the level of the renal hilum (within the connes of the paren­chyma). e AP renal pelvic diameter varies according to gestational age. erefore, the value chosen as the upper limit of normality strongly inuences the specicity and sensitivity of AP diameter as a predictor of genitourinary pathol­ogy at dierent stages in pregnancy. Although there is no universal consensus, a renal pelvic diameter of greater than 10 mm in the second trimester is generally regarded as a signicant nding, with an AP diameter of greater than 15mm being regarded as the upper threshold in the third trimester.
HYDRONEPHROSIS
Dilatation of the fetal urinary tract (fetal hydro­nephrosis) is the most common genitourinary abnormality identied on antenatal screening.
Society for Fetal Urology (SFU) classication
e SFU developed a grading system for neonatal and infant hydronephrosis based on a combination
Hydronephrosis / Classication Systems 45
https://t.me/medicina_free
of dilatation of the renal pelvis, calyceal dilatation and a subjective assessment of parenchymal thick­ness. ough originally devised for grading hydro­nephrosis postnatally, the SFU classication is also commonly applied to antenatal hydronephrosis. e SFU grading is based on the following criteria:
Grade 0: Normal ultrasound ndings with no
dilatation Grade I: Dilatation conned to the renal pelvis Grade II: Dilatation of the renal pelvis accompa-
nied by dilatation of the major calyces Grade III: Dilatation of the renal pelvis accom-
panied by dilatation of the major and minor
calyces Grade IV: As for Grade III plus thinning of the
renal cortex (Figure 4.1)
Urinary Tract Dilation (UTD) classication
e UTD classication was devised by a multi­disciplinary consensus panel with the aims of unifying dierent grading systems, introduc­ing consistency into the terminology applied to antenatal and postnatal classication of hydro­nephrosis and correlating the antenatal grading with the clinical signicance of the underlying genitourinary abnormality. e classication encompasses the following ultrasound ndings:
1. Anterior-posterior renal pelvic diameter
2. Calyceal dilation
3. Renal parenchymal thickness
4. Renal parenchymal appearance (echo-
genicity, corticomedullary dierentiation, cortical cysts)
5. Ureteral dilation
6. Bladder pathology (ureterocele, wall thicken-
ing, dilated posterior urethra)
7. Oligohydramnios (antenatal classication
only)
is is the only classication to take account of ureteral and lower urinary tract abnormali­ties and the only one to oer clinical guidance according to risk. Patients are allocated to dif­ferent risk categories by a combination of ultra­sound ndings (with the most severe ndings taking precedence) and gestational or postnatal age. Antenatal and postnatal risk categories are denoted by A or P, respectively. ere are two antenatal risk categories: A1 (low risk) and A2-3 (intermediate/high risk) and three postnatal risk categories: P1 (low risk), P2 (intermediate risk), and P3 (high risk). (Figure 4.2)
Each risk category has associated clini­cal recommendations to guide the clinician (Figure 4.3). e physiological reduction in urine output which normally occurs during the rst 48 hours aer birth may reduce the sensitivity of ultrasound for the detection of hydronephro­sis during this period. Decision-making should therefore be based on ultrasound ndings aer 48 hours.
Figure 4.1 (a) Unilateral SFU grade 4 hydronephrosis with blunted calyces and thinned, echogenic
renal cortex at 22/40 weeks. (b) Bilateral SFU grade 4 hydronephrosis at 22/40 weeks.
46 Prenatal Diagnosis
https://t.me/medicina_free
Figure 4.2 UTD risk-based sonographic classication of hydronephrosis. (A) Prenatal classication.
Central and peripheral calyceal dilation may be difcult to evaluate early in gestation. Oligohydramnios must be suspected to result from a genitourinary cause. (B) Postnatal sonographic classication of hydronephrosis.
Postnatal investigation
Prenatally detected hydronephrosis is a non­specic nding and, where appropriate, further imaging investigations are required to establish the urological diagnosis. Postnatal diagnostic imaging always begins with a renal and bladder ultrasound. Depending on the initial ultrasound ndings and other factors, further investigations typically comprise a voiding cystourethrogram (VCUG) and functional isotope renography.
Mild hydronephrosis
Dilatation of the renal pelvis corresponding to Grade I on the SFU scale is a common nding which is present in 1:100 pregnancies. It is oen a self-limiting physiological phenomenon – which resolves spontaneously by the third tri­mester in more than 50% of cases. ere is now general agreement that this nding can usually be disregarded if the dilatation is conned to the renal pelvis and the AP diameter is less than 10mm. Follow up studies of children born with mild hydronephrosis have found that their inci­dence of UTIs and bladder symptoms in child­hood is no higher than in age matched normal controls. Nevertheless, the discovery of mild
hydronephrosis on routine antenatal ultraso­nography can cause considerable parental anx­iety and it is important that parents are given appropriate reassurance. It is also important that newborn infants with mild hydronephro­sis are not submitted to unnecessary, invasive investigations. Mild hydronephrosis may be a marker of underlying VUR but when this is the case it usually low grade and of doubtful clini­cal signicance. SFU and AUA guidelines do not advocate routine VCUG in infants with mild (SFU Grade I) prenatally detected hydronephro­sis but recommend that VCUG is used more selectively on the basis of additional ultrasono­graphic criteria.
Ureteropelvic junction (UPJ) obstruction
e most common underlying cause of clini­cally signicant hydronephrosis is UPJ obstruc­tion, which occurs in approximately 1 in 500 live births. UPJ obstruction is characterized by partial or intermittent occlusion of the lumen of the UPJ. Dilatation is conned to the renal collecting sys­tems unless the UPJ obstruction is associated w ith other urinary tract abnormalities – in which case ureteral dilatation and/or bladder abnormalities
Hydronephrosis / Classication Systems 47
https://t.me/medicina_free
Figure 4.3 UTD risk-based guidelines for management of hydronephrosis. (A) Follow-up
recommendations for prenatally diagnosed hydronephrosis. (B) Management recommendations based on postnatal ultrasound.
may also be present. Boys are aected more com­monly than girls, and approximately 10% of cases are bilateral. ere is usually a good correla­tion between the degree of hydronephrosis and the severity of obstruction and impact on renal function (as demonstrated by isotope renogra­phy). e indications for pyeloplasty and the arguments surrounding conservative or surgical
management of prenatally detected UPJ obstruc­tion are reviewed in greater detail in Chapter 7. In brief, it is generally agreed that early pyelo­plasty is indicated for infants with severe hydro­nephrosis and/or reduced dierential function. Pyeloplasty remains the surgical “gold standard” and has a very high success rate for the correction of UPJ obstruction.
48 Prenatal Diagnosis
https://t.me/medicina_free
Vesicoureteral reux
As noted already, VUR is one of the conditions which may give rise to prenatal hydronephrosis. However, there are no pathognomonic ultraso­nographic features and the diagnosis of VUR can only be reliably established on a postnatal VCUG. At one time this was performed routinely in all infants with prenatally detected hydronephrosis, regardless of severity. However, current SFU and AUA guidelines recommend that VCUG should be limited to infants with higher grades of hydro­nephrosis (III–IV on the SFU scale) and/or those with ureteral dilatation (hydroureter) or bladder abnormalities. is is considered in more detail in Chapter 6.
Other urological conditions
Primary megaureter accounts for around 5–10% of cases of fetal hydronephrosis. On ultrasound, the degree of ureteral dilatation may be dispro­portionally greater than the degree of renal dilata­tion. Aer 30 weeks gestation a ureteral diameter of greater than 7 mm is regarded as an abnormal nding constituting a diagnosis of megaureter. e postnatal investigation, classication, and management of megaureters are considered in
Chapter 7. Ureteroceles may be detected pre-
natally and are characterized by appearances of a thin septum or thin walled cystic structure within the bladder. is nding may be accom­panied by upper tract dilatation and bilateral hydronephrosis if the ureterocele has prolapsed into bladder outlet or urethra to cause outow obstruction. Similarly, ureteroceles which are associated with an ectopic ureter associated with the upper pole of a duplex kidney may be accompanied by ureteral dilatation and abnormal ultrasound appearances of the kidney itself. e postnatal assessment and management of ure­teroceles and upper tract duplication is addressed in Chapter 8.
Figure 4.4 Prenatal ultrasound showing a
distended bladder and dilated posterior urethra (arrow) in a fetus with posterior urethral valves.
ultrasound ndings such as a distended, thick walled bladder and dilated posterior urethra (keyhole sign) (Figure 4.4). Other ultrasound ndings may include changes in the renal paren­chyma denoting dysplasia, bladder diverticula, patent urachus, or rupture of a renal fornix or calyx with a perinephric urinoma or urinary ascites. Oligohydramnios and pulmonary hypo­plasia are indicative of severe renal dysplasia and predictors of a poor prognosis. e role of fetal intervention is described later in this chapter and the postnatal investigation and management of PUV is reviewed in Chapter 9.
Postnatal Management: General Considerations
e UTD guidelines leave much to the discretion of the clinician. ere is signicant variation in the empirical use of prophylactic antibiotics and indications for VCUG and isotope renography.
Prophylactic antibiotics
Posterior urethral valves (PUV)
Bilateral hydronephrosis in a male fetus is highly suggestive of posterior urethral valves and the diagnosis is strongly supported by additional
e published evidence provides limited support for the use of antibiotic prophylaxis in infants born with prenatally detected hydronephrosis. A randomized controlled trial comparing trim­ethoprim to placebo in infants with prenatally
Non-hydronephrotic anomalies 49
https://t.me/medicina_free
detected SFU Grade III–IV hydronephrosis is ongoing. e antibiotics used most commonly for urinary prophylaxis in neonates include amoxicil­lin (10–20 mg/kg/day), cephalexin (10 mg/kg/day), and trimethoprim (2 mg/kg/day). Trimethoprim­sulfamethoxazole and nitrofurantoin are contra­indicated because of the risks of kernicterus and hemolytic anemia, respectively. e following pre­natally detected urological conditions are gener­ally regarded as indications for postnatal antibiotic prophylaxis:
Lower urinary tract obstruction (e.g. poste­rior urethral valves, urethral atresia)
Ureterovesical junction obstruction (e.g. obstructing megaureter, ectopic ureter, or ureterocele)
Moderate to high grades of vesicoureteral reux in girls
Voiding cystourethrogram (VCUG)
e generally accepted indications for postnatal VCUG include:
Abnormal bladder (e.g. thick wall, keyhole sign, diverticula)
Bilateral hydronephrosis in boys (a VCUG should always be performed prior to dis­charge from the hospital to investigate for posterior urethral valves)
Multicystic dysplastic kidney with an abnor­mal contralateral kidney
Ureteral dilation
Duplex kidney with hydronephrosis in either moiety
Large ureterocele (to investigate possible prolapse)
Renography
e most widely used radionuclide scan is the technetium-99 m-mercaptoacetyltriglycine (MAG-3) diuretic renogram. is has the advantage of com­bining information on drainage with an assess­ment of dierential renal function. e technical aspects are detailed in Chapter 3. Radionuclide scans are less reliable and the results are more
dicult to interpret in neonates because of the functional immaturity of their kidneys. For this reason radionuclide scans should be deferred until 6–8 weeks. of age. e indications for diuretic renography include:
Moderate to severe hydronephrosis (anterior-
posterior renal pelvic diameter >10mm, SFU
Grade III–IV) with absence of vesicoureteral
reux
Establishing baseline function prior to sur-
gery to relieve obstruction (e.g. UPJ obstruc-
tion, UVJ obstruction)
Conrming poor function in a kidney prior
to nephrectomy
NON-HYDRONEPHROTIC ANOMALIES
Urological abnormalities which are associated with hydronephrosis are more readily detected on prenatal ultrasonography than those which are not. Nevertheless, other urologic abnor­malities can be identied by prenatal ultra­sound – and genital anomalies are occasionally diagnosed prenatally. e nding of a urologi­cal anomaly may also lead to the diagnosis of a more severe, complex congenital abnormality, or syndrome.
e anatomical features and clinical aspects of abnormalities of ascent and fusion are described in Chapter 14. Renal ectopia is fre­quently associated with other congenital anom­alies and may be a component of more complex syndromes such as VACTERL and agenesis of the corpus callosum.
A simple ectopic kidney may be located any­where along the embryological path of ascent to the lumbar renal fossa. Pelvic kidneys are the most common form of simple ectopia­accounting for 60% of all cases. In addition to its abnormal location, a pelvic kidney is frequently malrotated, hypoplastic, and irregular in shape. A horseshoe kidney is formed by fusion of the le and right kidneys which, in the major­ity of cases are joined at their lower poles by an isthmus of renal parenchyma or dysplastic or
50 Prenatal Diagnosis
https://t.me/medicina_free
brous tissue. Horseshoe kidneys are commonly found in association with other abnormalities or syndromes, notably Turner’s syndrome and abnormalities of the central nervous system, the gastrointestinal tract, and the skeletal and car­diovascular systems. Crossed renal ectopia is a rare form of renal ectopia in which both kidneys are located on the same side of midline. In most cases the kidneys are fused but the kidney which is abnormally located retains its vessels and ure­ters from the contralateral side. e abnormal­ity may either be visualized directly by prenatal ultrasonography or may be identied indirectly when a kidney cannot be visualized in the con­tralateral renal fossa. Further investigation is usually indicated aer birth because of the rela­tively high incidence of VUR and other abnor­malities. Unilateral renal agenesis occurs in 1 in around 1300 pregnancies and is more common in twins. On ultrasound, the lumbar fossa is empty and the adrenal gland appears elongated. e contralateral kidney may demonstrate com­pensatory hypertrophy. Unilateral renal agenesis is typically a sporadic anomaly but can occur in association with chromosomal or developmen­tal defects such as DiGeorge syndrome or the
VACTERL complex. It may also occur in con­junction with genital anomalies, notably absence of the vas deferens in males and Müllerian anom­alies in girls. Bilateral renal agenesis occurs in around 1 in 4000 pregnancies. Ultrasound fea­tures comprise absence of both kidneys (empty lumbar fossae) early anhydramnios, and lack of bladder lling. If the pregnancy proceeds to term, bilateral renal agenesis generally results in the early demise of the infant from pulmonary insuf­ciency and renal failure.
Cystic renal disease is reviewed in detail in
Chapter 10. e form most commonly detected by
prenatal ultrasonography is autosomal recessive polycystic kidney disease (ARPKD) which occurs in 1 in 20,000 live births. On ultrasound, the kidneys typically appear markedly enlarged and echogenic with poor or even reversed corticome­dullary dierentiation (Figure 4.5). However, the kidneys may appear normal up to the 20th week of gestation.
Unilateral multicystic dysplastic kidney (MCDK) is one of the commonest prenatally detected renal malformations (Figure 4.6). is partly because of its relative frequency (between 1:2500 and 1:4000 pregnancies) and partly
Figure 4.5 Prenatal imaging at 33/40 weeks showed markedly enlarged, bright kidneys consistent
with infantile ARPKD. (A) Ultrasound shows echogenic kidneys. (B) MRI shows T2 hyperintense kidneys. The fetal bladder is empty, and there is severe oligohydramnios.
Non-hydronephrotic anomalies / Syndromes, Genital Anomalies 51
https://t.me/medicina_free
Fetal intervention
Fetal diagnosis prompts the question of fetal inter­vention. Of the currently available fetal interven­tions, decompression of an obstructed fetal urinary tract and intrauterine closure of myelomeningocele are those of greatest relevance to pediatric urology. To date, the outcomes of both forms of interven­tion have been disappointing, with a signicant incidence of perinatal complications and little evi­dence of benet for bladder and renal function.
Vesicoamniotic shunting
Figure 4.6 Multicystic dysplastic kidney at
22/40 weeks.
because of the ease with which the uid-lled cysts can be visualized on ultrasound. Bilateral MCDK has an incidence of around 1:20,000 and is a lethal condition. e further investigation of MCDKs and the controversies surrounding their management are considered in Chapter 10.
Syndromes, Genital Anomalies
Many conditions involving the genitourinary system are routinely diagnosed prenatally. Among the commonest are myelomeningocele and sacral agenesis – which almost invariably give rise to neurogenic bladder dysfunction. Cloacal anomalies may be suspected in fetuses with a pelvic cystic structure (hydrocolpos), poorly visualized bladder, and bilateral hydro­nephrosis. Although bladder exstrophy is associ­ated with a number of diagnostic features these are not always easy to detect with the result that only 50% of cases are diagnosed prenatally. Bowel distension may suggest an anorectal malforma­tion, particularly if this is accompanied by other features of VACTERL (vertebral, anorectal, car­diac, esophageal stula, renal, limb) anomalies. Isolated genital anomalies can also be detected prenatally – the most common being virilized genitalia in a female with 46 XX DSD due to con­genital adrenal hyperplasia. Other forms of DSD may be identied because of discordance between genotype and prenatal ultrasonography.
e aims of this form of prenatal intervention for bladder outlet obstruction are:
1. To prevent pulmonary hypoplasia (the main
cause of neonatal death)
2. To improve the outcome for renal function
3. To improve the outlook for bladder function
e commonest indicat ion is to alleviate t he eects of outow obstruction due to posterior urethral valves. Although, fetal cystoscopic valve ablation and open vesicostomy have been reported the most commonly performed procedure consists of decompressing the obstructed urinary tract by use of a vesicoamniotic shunt. Under ultrasound guidance a trocar is inserted through the mater­nal abdominal wall and uterus into the bladder. A double-pigtail shunt is then introduced, with one end in the fetal bladder and the other in the amni­otic cavity. If there is oligohydramnios it may be necessary to infuse uid into the amniotic cavity to facilitate this maneuver (Figure 4.7).
Vesicoamniotic shunting is usually performed before 26 weeks. When performed aer 26 weeks it is unlikely to lead to any improvement in pulmonary function. e selection criteria are quite complex and include; recent onset of oli­gohydramnios, functioning kidneys capable of urine output, normal karyotype and absence of co-existing congenital abnormalities. Serial fetal urine sampling is recommended to aid selection for intervention. High urinary levels of sodium, calcium, and β2-microglobulin are predictors of poor renal function (Table 4 .1). e combination of unfavorable fetal urine electrolyte markers